Literature DB >> 6608925

Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance.

H M Moutsopoulos, H Giotaki, P J Maddison, A C Mavridis, A A Drosos, F N Skopouli.   

Abstract

One hundred and twenty-four sera from Greek patients with autoimmune rheumatic diseases (29 with systemic lupus erythematosus (SLE), 24 with scleroderma, 11 with primary Sjögren's syndrome (SS), and 60 with rheumatoid arthritis (RA) were tested for antibodies to nRNP, Sm, Scl-70, Ro(SSA), and La(SSB) cellular antigens. The incidence of these antibodies in the different groups of patients examined, did not differ overall from that described previously. It was noted, however, that antibodies to Sm were very infrequently found in Greek patients with SLE and anti-Ro positive patients with SLE did not have the clinical manifestations described by other workers. Finally, it was found that anti-Ro positive patients with RA experienced a high frequency of side effects from penicillamine-D. The significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608925      PMCID: PMC1001484          DOI: 10.1136/ard.43.2.285

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus.

Authors:  M F Miniter; B D Stollar; V Agnello
Journal:  Arthritis Rheum       Date:  1979-09

2.  Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.

Authors:  M Nishikai; M Reichlin
Journal:  Arthritis Rheum       Date:  1980-08

3.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

4.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

Authors:  P J Maddison; T T Provost; M Reichlin
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

5.  Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis.

Authors:  H M Moutsopoulos; B L Webber; T P Vlagopoulos; T M Chused; J L Decker
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

6.  Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.

Authors:  D A Bell; P J Maddison
Journal:  Arthritis Rheum       Date:  1980-11

7.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

Authors:  E M Tan; G P Rodnan; I Garcia; Y Moroi; M J Fritzler; C Peebles
Journal:  Arthritis Rheum       Date:  1980-06

8.  Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.

Authors:  D M Winn; J F Wolfe; D A Lindberg; F H Fristoe; L Kingsland; G C Sharp
Journal:  Arthritis Rheum       Date:  1979-12

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

10.  Penicillamine and the SLE syndrome.

Authors:  J M Walshe
Journal:  J Rheumatol Suppl       Date:  1981 Jan-Feb
View more
  9 in total

Review 1.  Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.

Authors:  H M Moutsopoulos; L V Zerva
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

2.  Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

Authors:  F Shokri; R A Mageed; G D Kitas; P Katsikis; H M Moutsopoulos; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Multiple tendon ruptures in a patient affected by anti-SSA/Ro antibody positive rheumatoid arthritis.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; M Randon; M L Pacor; L M Bambara
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

4.  Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.

Authors:  P D Katsikis; P Y Youinou; V Galanopoulou; N M Papadopoulos; A G Tzioufas; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

5.  Lack of HLA-antigen association in Greek rheumatoid arthritis patients.

Authors:  C A Papasteriades; I D Kappou; F N Skopouli; M N Barla; G A Fostiropoulos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

6.  Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects.

Authors:  H M Moutsopoulos; F N Skopouli; A K Sarras; C Tsampoulas; A K Mavridis; S H Constantopoulos; P J Maddison
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

7.  Antibodies to extractable cellular antigens in Spanish systemic lupus erythematosus (SLE) patients.

Authors:  P E Carreira; I Mateo; G Garcia; G Garrido; J Gomez-Reino
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

8.  Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patients.

Authors:  A E Gharavi; F N Skopouli; B M Patel; G R Hughes; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 9.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.